(MED) MEDICLIN Aktiengesellschaft - Ratings and Ratios

MEDICLIN Aktiengesellschaft (XETRA:MED) is a German healthcare provider specializing in hospital operations and medical services. The company operates through three primary segments: Post-Acute, Acute, and Other Activities, offering a wide range of medical specialties including neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, and urology. Additionally, the company provides ENT and acute outpatient services, positioning itself as a comprehensive healthcare provider. MEDICLIN owns and operates clinics, rehabilitation care facilities, nursing care centers, and medical care centers across multiple German federal states, with a strong presence in regions such as Baden-Württemberg and Rhineland-Palatinate. Founded in 1994 and headquartered in Offenburg, Germany, the company has established itself as a key player in Germanys healthcare sector.

From a technical perspective, MEDICLINs stock (XETRA:MED) shows a last price of 2.90 EUR, with a 20-day average volume of 7,529 shares. The stocks short-term trend indicates a slight decline, as the SMA 20 (2.95) is marginally above the current price, while the SMA 50 (2.74) and SMA 200 (2.57) suggest a longer-term downtrend. The ATR of 0.07 reflects low volatility. On the fundamental side, the company has a market cap of 138.70M EUR, with a price-to-book ratio of 0.65 and a price-to-sales ratio of 0.18, indicating undervaluation relative to its assets and revenue. However, the return on equity (RoE) stands at -5.26%, signaling ongoing profitability challenges.